Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10


Targeting Melanoma with Cancer-Killing Viruses.

Zhang T, Suryawanshi YR, Woyczesczyk HM, Essani K.

Open Virol J. 2017 Mar 31;11:28-47. doi: 10.2174/1874357901711010028. eCollection 2017.


Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs.

Braidwood L, Graham SV, Graham A, Conner J.

Oncolytic Virother. 2013 Dec 4;2:57-74. doi: 10.2147/OV.S52601. eCollection 2013. Review.


Oncolytic viruses in the treatment of bladder cancer.

Potts KG, Hitt MM, Moore RB.

Adv Urol. 2012;2012:404581. doi: 10.1155/2012/404581. Epub 2012 Jul 29.


Biological effects of a de novo designed myxoma virus peptide analogue: evaluation of cytotoxicity on tumor cells.

Istivan TS, Pirogova E, Gan E, Almansour NM, Coloe PJ, Cosic I.

PLoS One. 2011;6(9):e24809. doi: 10.1371/journal.pone.0024809. Epub 2011 Sep 19.


Targeting HSV-1 virions for specific binding to epidermal growth factor receptor-vIII-bearing tumor cells.

Grandi P, Fernandez J, Szentirmai O, Carter R, Gianni D, Sena-Esteves M, Breakefield XO.

Cancer Gene Ther. 2010 Sep;17(9):655-63. doi: 10.1038/cgt.2010.22. Epub 2010 May 28.


Effects of herpes simplex virus amplicon transduction on murine dendritic cells.

Chiu YG, Bowers WJ, Lim ST, Ryan DA, Federoff HJ.

Hum Gene Ther. 2009 May;20(5):442-52. doi: 10.1089/hum.2008.160.


Recombinant Newcastle disease virus as a vaccine vector for cancer therapy.

Vigil A, Martinez O, Chua MA, GarcĂ­a-Sastre A.

Mol Ther. 2008 Nov;16(11):1883-90. doi: 10.1038/mt.2008.181. Epub 2008 Aug 19.


Herpes simplex virus NV1020 as a novel and promising therapy for hepatic malignancy.

Kelly KJ, Wong J, Fong Y.

Expert Opin Investig Drugs. 2008 Jul;17(7):1105-13. doi: 10.1517/13543784.17.7.1105 . Review.


Utility of a herpes oncolytic virus for the detection of neural invasion by cancer.

Gil Z, Kelly KJ, Brader P, Shah JP, Fong Y, Wong RJ.

Neoplasia. 2008 Apr;10(4):347-53.


Use of an oncolytic virus secreting GM-CSF as combined oncolytic and immunotherapy for treatment of colorectal and hepatic adenocarcinomas.

Malhotra S, Kim T, Zager J, Bennett J, Ebright M, D'Angelica M, Fong Y.

Surgery. 2007 Apr;141(4):520-9. Epub 2007 Feb 14.

Supplemental Content

Support Center